The Italian newspaper “Lastamba” reported that the European Union might not extend contracts with “AstraZeneca” and “Johnson & Johnson” regarding their anti-Corona virus vaccines for the next year.
The newspaper indicated that Italian Prime Minister Mario Draghi and other European heads of government would decide not to extend contracts with companies that produce vaccines based on viral vector technology.
The restrictions may also affect the Russian “Sputnik V” vaccine, which the European Medicines Agency has not yet authorized, and the Italian Reithera vaccine.
Next year, Italy and other European Union countries will use only the “Pfizer” and “Moderna” vaccines, both messenger RNA vaccines.
According to the newspaper, the second option is under study. It requires an extension of contracts, but with a reduction in the number of doses provided under it and a shortening of the use of viral vector vaccines for people over the age of 60 years, as the available data indicate that they are not exposed to blood clots after receiving this type of vaccination.
It is noteworthy that many European countries have suspended using the “AstraZeneca” vaccine after reports of blood clots that may be related to the use of the vaccine. Denmark announced that it had abandoned the use of the “AstraZeneca” vaccine completely.
After AstraZeneca, the Johnson & Johnson vaccine raised concerns for the same reasons.
Source: “Lastamba” newspaper